Analyst Price Target is $27.00
▲ +13.30% Upside Potential
This price target is based on 3 analysts offering 12 month price targets for National Research in the last 3 months. The average price target is $27.00, with a high forecast of $27.00 and a low forecast of $27.00. The average price target represents a 13.30% upside from the last price of $23.83.
Current Consensus is
Hold
The current consensus among 3 polled investment analysts is to hold stock in National Research. This rating changed within the last month from a Moderate Buy consensus rating.
National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty. The company also offers marketing solutions that allow the tracking of awareness, perception, and consistency of healthcare brands; assessment of competitive differentiators; and enhanced segmentation tools to evaluate needs, wants, and behaviors of communities through real-time competitive assessments and enhanced segmentation tools. In addition, it provides experience solutions, such as patient experience, employee engagement, health risk assessments, care transition, and improvement tools. Further, the company provides reputation solutions that allow healthcare organizations to share a picture of their organization and ensure that timely and relevant content informs consumer decision-making; and governance solutions for not-for-profit hospital and health system boards of directors, executives, and physician leadership. National Research Corporation was founded in 1981 and is headquartered in Lincoln, Nebraska.
Read More
